Development and internal validation of a predictive model for the estimation of pheochromocytoma recurrence risk after radical surgery. Issue 3 (15th February 2022)

• Record Type: Journal Article
• Authors: Parasiliti-Caprino, Mirko; Bioletto, Fabio; Lopez, Chiara; Maletta, Francesca; Caputo, Marina; Gasco, Valentina; La Grotta, Antonio; Limone, Paolo; Borretta, Giorgio; Volante, Marco; Papotti, Mauro; Terzolo, Massimo; Morino, Mario; Pasini, Barbara; Veglio, Franco; Ghigo, Ezio; Arvat, Emanuela; Maccario, Mauro
• Is Part Of: European journal of endocrinology. Volume 186:Issue 3(2022)
• Page Start: 399
• Page End: 406
• Publication Date: 2022-02-15
• Subjects: Endocrinology -- Periodicals; 616.4005
• DOI: 10.1530/EJE-21-0370
• Languages: English
• ISSNs: 0804-4643

Abstract

Abstract: Objective: Various features have been identified as predictors of relapse after complete resection of pheochromocytoma, but a comprehensive multivariable model for recurrence risk prediction is lacking. The aim of this study was to develop and internally validate an integrated predictive model for post-surgical recurrence of pheochromocytoma. Methods: The present research retrospectively enrolled 177 patients affected by pheochromocytoma and submitted to radical surgery from 1990 to 2016, in nine referral centers for adrenal diseases. Cox regression analysis was adopted for model development, and a bootstrapping procedure was used for internal validation. Results: Variables independently associated with recurrence were tumor size (hazard ratio (HR): 1.01, 95% CI: 1.00–1.02), positive genetic testing (HR: 5.14, 95% CI: 2.10–12.55), age (HR: 0.97, 95% CI: 0.94–0.99), and Pheochromocytoma of the Adrenal Gland Scaled Score (PASS) (HR: 1.16, 95% CI: 1.04–1.29). The predictive performance of the overall model, evaluated by Somers' D, was equal to 0.594, and was significantly higher than the ones of any single predictor alone ( P = 0.002 compared to tumor size; P = 0.004 compared to genetic testing; P = 0.048 compared to age; P = 0.006 compared to PASS). Internal validation by bootstrapping techniques estimated an optimistic bias of 6.3%, which reassured about a small tendency towards overfit. Conclusions: We proposed a multivariable model for the prediction of post-surgical recurrence of pheochromocytoma, derived by the integration of genetic, histopathological, and clinical data. This predictive tool may be of value for a comprehensive tailoring of post-surgical follow-up in radically operated pheochromocytoma patients.